Itschak Lamensdorf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Itschak Lamensdorf has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Graeme Eisenhofer
Clinical Neuroscience Branch, NINDS, Building 10, Room 6N252, 10 Center Drive, MSC 1620, National Institutes of Health, Bethesda, MD 20892-1620, USA
3 shared publicationsJudith Harvey-White
Clinical Neuroscience Branch, Building 10, Room 6N256, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1620, USA
3 shared publicationsAmotz Nechushtan
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA
2 shared publicationsEduardo Rojas
Laboratory of Cell Biochemistry and Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
2 shared publicationsIrwin J. Kopin
Clinical Neuroscience Branch, NINDS, Building 10, Room 6N252, 10 Center Drive, MSC 1620, National Institutes of Health, Bethesda, MD 20892-1620, USA
2 shared publicationsAmotz Nechustan
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publication
Latest Publications
- 1 June 2000
- Published by Elsevier in Brain Research
- Vol. 868 (2) , 191-201
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells
- 1 June 2000
- Published by Elsevier in Brain Research
- Vol. 868 (2) , 191-201
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells
- 1 June 2000
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 361 (6) , 654-664
Acidic dopamine metabolites are actively extruded from PC12 cells by a novel sulfonylurea-sensitive transporter
Incubation of PC12 cells with the sulfonylurea drug, glipizide (1–100 µM), increased intracellular levels of the acidic metabolites of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). The levels of these acids in the medium were decreased, indicating the presence of a sulfonylurea-sensitive organic anion transporter. In the present study, we demonstrate that the sulfonylurea-sensitive transport of acidic dopamine metabolites is unidirectional, ATP dependent, unaffected by ouabain or by tetrodotoxin and blocked by drugs that interact with the multidrug-resistance protein-1 (MRP1). However, over-expression of MRP1 did not affect transport of the acid metabolites. The pharmacological profile and ion dependence of the transporter also differs from that of known ATP-binding cassette (ABC) family members. Using microdialysis, we also demonstrated a sulfonylurea-sensitive transport process in the striatum of freely moving rats. These results show that acidic dopamine metabolites are actively secreted from dopaminergic cells into surrounding extracellular fluid by a previously undescribed transporter.
- 1 June 2000
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 361 (6) , 654-664
Acidic dopamine metabolites are actively extruded from PC12 cells by a novel sulfonylurea-sensitive transporter
Incubation of PC12 cells with the sulfonylurea drug, glipizide (1–100 µM), increased intracellular levels of the acidic metabolites of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). The levels of these acids in the medium were decreased, indicating the presence of a sulfonylurea-sensitive organic anion transporter. In the present study, we demonstrate that the sulfonylurea-sensitive transport of acidic dopamine metabolites is unidirectional, ATP dependent, unaffected by ouabain or by tetrodotoxin and blocked by drugs that interact with the multidrug-resistance protein-1 (MRP1). However, over-expression of MRP1 did not affect transport of the acid metabolites. The pharmacological profile and ion dependence of the transporter also differs from that of known ATP-binding cassette (ABC) family members. Using microdialysis, we also demonstrated a sulfonylurea-sensitive transport process in the striatum of freely moving rats. These results show that acidic dopamine metabolites are actively secreted from dopaminergic cells into surrounding extracellular fluid by a previously undescribed transporter.
- 1 May 2000
- Published by Wiley in Journal of Neuroscience Research
- Vol. 60 (4) , 552-558
Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde
3,4‐Dihydroxyphenylacetaldehyde (DOPAL) has been reported to be a toxic metabolite formed by the oxidative‐deamination of dopamine (DA) catalyzed by monoamine oxidase. This aldehyde is either oxidized to 3,4‐dihydroxyphenylacetic acid (DOPAC) by aldehyde dehydrogenase, an NAD‐dependent enzyme or reduced to 3,4‐dihydroxyphenylethanol (DOPET) by aldehyde or aldose reductase. In the present study we examined whether levels of DOPAL are elevated by inhibition of the mitochondrial respiratory chain. Using inhibitors of mitochondrial complexes I, II, III and IV we found that inhibition of complex I and III increased levels of DOPAL and DOPET. Nerve growth factor‐induced differentiation of PC12 cells markedly potentiated DOPAL and DOPET accumulation in response to metabolic stress. DOPAL was toxic to differentiated PC12 as well as to SK‐N‐SH cell lines. Because complex I dysfunction has been implicated in the pathogenesis of Parkinson's disease, the accumulation of DOPAL may explain the vulnerability of the dopaminergic system to complex I inhibition. The rapid appearance of DOPAL and DOPET after inhibition of complex I may be a useful early index of oxidative stress in DA‐forming neurons. J. Neurosci. Res. 60:552–558, 2000
- 1 May 2000
- Published by Wiley in Journal of Neuroscience Research
- Vol. 60 (4) , 552-558
Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde
3,4‐Dihydroxyphenylacetaldehyde (DOPAL) has been reported to be a toxic metabolite formed by the oxidative‐deamination of dopamine (DA) catalyzed by monoamine oxidase. This aldehyde is either oxidized to 3,4‐dihydroxyphenylacetic acid (DOPAC) by aldehyde dehydrogenase, an NAD‐dependent enzyme or reduced to 3,4‐dihydroxyphenylethanol (DOPET) by aldehyde or aldose reductase. In the present study we examined whether levels of DOPAL are elevated by inhibition of the mitochondrial respiratory chain. Using inhibitors of mitochondrial complexes I, II, III and IV we found that inhibition of complex I and III increased levels of DOPAL and DOPET. Nerve growth factor‐induced differentiation of PC12 cells markedly potentiated DOPAL and DOPET accumulation in response to metabolic stress. DOPAL was toxic to differentiated PC12 as well as to SK‐N‐SH cell lines. Because complex I dysfunction has been implicated in the pathogenesis of Parkinson's disease, the accumulation of DOPAL may explain the vulnerability of the dopaminergic system to complex I inhibition. The rapid appearance of DOPAL and DOPET after inhibition of complex I may be a useful early index of oxidative stress in DA‐forming neurons. J. Neurosci. Res. 60:552–558, 2000
- 1 January 2000
- Published by Elsevier in European Journal of Pharmacology
- Vol. 388 (2) , 147-154
Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells
- 1 January 2000
- Published by Elsevier in European Journal of Pharmacology
- Vol. 388 (2) , 147-154
Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells